Revista de gastroenterologia de Mexico (English)最新文献

{"title":"Response to “Fecal microbiota transplantation in recurrent Clostridioides difficile: Is greater methodological rigor and the analysis of other populations relevant?”","authors":"P. Núñez, R. Quera, C. von Muhlenbrock","doi":"10.1016/j.rgmxen.2025.09.023","DOIUrl":"10.1016/j.rgmxen.2025.09.023","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 507-508"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acute phlegmonous gastritis. A rare case of acute abdominal pain","authors":"L. Villalonga Lopez-Uribarri, J. Carrascosa Gil, H. Rodrigo Pérez","doi":"10.1016/j.rgmxen.2025.09.011","DOIUrl":"10.1016/j.rgmxen.2025.09.011","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 477-478"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Upper gastrointestinal bleeding in a patient with Kawasaki disease: A case report and literature review","authors":"C.A. González-Heredia , A.Y. Martínez-Vázquez , J.A. Galindo-Martínez","doi":"10.1016/j.rgmxen.2025.09.013","DOIUrl":"10.1016/j.rgmxen.2025.09.013","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 481-483"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gastroenteropancreatic neuroendocrine tumors: A retrospective study conducted in the Colombian Southwest","authors":"J.C. Bravo-Ocaña ,&nbsp;N. López-Moreno ,&nbsp;E.D. Salazar-Cardona ,&nbsp;A.F. Mejía-Hurtado ,&nbsp;V. Gutiérrez-Aragón ,&nbsp;M. Gonzáles-Hurtado ,&nbsp;L.A. Satizabal-Mayor ,&nbsp;J.F. Lbasseauny-Morales ,&nbsp;N. Rojas-Rojas ,&nbsp;C.A. Rojas-Rodríguez","doi":"10.1016/j.rgmxen.2025.09.009","DOIUrl":"10.1016/j.rgmxen.2025.09.009","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare neoplasms originating in neuroendocrine cells from the gastric mucosa and submucosa, small intestine, large intestine, rectum, and pancreas. Our aim was to describe their histopathologic, endoscopic, and clinical characteristics and the experience with these tumors at a tertiary care hospital center in the Colombian Southwest.</div></div><div><h3>Materials and methods</h3><div>A retrospective, analytic, observational, and descriptive study included 93 patients diagnosed with GEP-NETs, within the time frame of 2018 and 2022. Their clinical histories were reviewed to collect the sociodemographic, clinical, endoscopic, pathologic, treatment, follow-up, and survival data.</div></div><div><h3>Results</h3><div>Median patient age was 55.8 years, and 60.2% were women. A total of 78.5% of the patients presented with symptoms, the most common of which was abdominal pain (78.1%). The tumors were mainly located in the stomach (32.3%) and small intestine (23.7%). Histopathologically, 53.8% of the tumors were grade1, 30.1% were grade 2, 9.68% were grade 3, and 7.52% were carcinomas. Tumor location was significantly related to stage; the majority of tumors in stage I were in the stomach, whereas the stage IV tumors were in the small intestine. At the last evaluation, 40.9% of the patients were disease-free, disease was stable in 24.7% and progressive in 11.8%, and 18.3% of the patients died.</div></div><div><h3>Conclusions</h3><div>GEP-NETs are clinically heterogeneous, and their early diagnosis is dependent on the recognition of lesions in endoscopic and imaging studies. Early tumors are mainly located in the stomach and advanced tumors in the small intestine, with metastases in the liver and regional lymph nodes. The present study suggests the importance of disease awareness in the early detection of GEP-NETs; said factor, combined with timely interdisciplinary management, could significantly impact patient outcomes.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 357-365"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145034852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Descriptive study on the use of colonoscopy as a screening method for colorectal cancer","authors":"F.E. Jabif,&nbsp;P.N. Cherne,&nbsp;C. Pintos,&nbsp;J.A. Pollán,&nbsp;A. Murujosa","doi":"10.1016/j.rgmxen.2024.11.008","DOIUrl":"10.1016/j.rgmxen.2024.11.008","url":null,"abstract":"<div><h3>Introduction and aims</h3><div>The aim of this study was to estimate the number of patients diagnosed with colorectal cancer (CRC) that underwent their first screening colonoscopy and to describe the endoscopic and anatomopathologic findings and characteristics of the patients that had a screening colonoscopy for CRC.</div></div><div><h3>Materials and methods</h3><div>A cross-sectional study was conducted that included patients aged 50 to 79 years, with prepaid healthcare at a tertiary care hospital, that underwent a first colonoscopy within the time frame of 2013 and 2022. The demographic data, endoscopic findings, and biopsy results were collected. Patients with a history of previous colonoscopy or a previous CRC diagnosis were excluded. Descriptive statistics were utilized for the data analysis.</div></div><div><h3>Results</h3><div>Of 28,286 colonoscopies performed, 19,222 (68%) were for CRC screening. Mean patient age was 61 years, with a predominance of women (59.5%). The prevalence of CRC diagnosis was 0.6% and the most common findings were polyps (36.7%) and diverticula (35.5%). A total of 118 cases of CRC were diagnosed, as a result of the first colonoscopy. The post-colonoscopy hospitalization rate was 1.14%.</div></div><div><h3>Conclusions</h3><div>This study provides relevant information on the characteristics of the population undergoing CRC screening at our center. Our data contribute to having a better understanding of the profile of patients that access screening and provides a solid descriptive base through which clinical practices, diagnostic method quality, and screening program results can be evaluated.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 366-372"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145034861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Consensus on the diagnosis, treatment, and follow-up in children and adolescents with overweight and obesity of the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN)","authors":"Y. Rivera-Suazo ,&nbsp;J. Alberto-Meléndez ,&nbsp;J.E. Alfaro-Bolaños ,&nbsp;F.J. Álvarez-Chávez ,&nbsp;A.G. Ayala-Germán ,&nbsp;M.J. Galaviz-Ballesteros ,&nbsp;M. Higuera-Carillo ,&nbsp;C.L. Taquez-Castro ,&nbsp;A.L. Villa-Gómez ,&nbsp;B.N. Villaroel-Ibarra ,&nbsp;B.A. Alvarado-Cárcamo ,&nbsp;F.A. Reynoso-Zarzosa ,&nbsp;Y.B. Quiñones-Pacheco ,&nbsp;C.M. Timossi-Baldi ,&nbsp;R. Vázquez-Frias","doi":"10.1016/j.rgmxen.2025.09.006","DOIUrl":"10.1016/j.rgmxen.2025.09.006","url":null,"abstract":"<div><h3>Introduction and aims</h3><div>Childhood obesity is a pandemic with significant morbidity and mortality implications, impacting both quality of life and the economic burden on healthcare systems. Given the effects on health for the pediatric population, and aligned with the multidisciplinary management approach, the Obesity Working Group of the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN) summoned a group of healthcare professionals to develop a consensus on overweight and obesity. The aim of this document is to present those consensus results.</div></div><div><h3>Material and methods</h3><div>The LASPGHAN Obesity Working Group organized 6 working panels to formulate statements on diagnostic approach, treatment, and follow-up. We conducted a comprehensive review of the current literature across several databases utilizing different search criteria. Thirty-four panelists from the countries that make up the LASPGHAN were selected. They participated in an anonymous online voting process using the Delphi method. <em>A priori</em> consensus for each statement was defined as 80% agreement on a 3-point Likert scale.</div></div><div><h3>Results</h3><div>Twenty-six statements were discussed and voted upon, resulting in the final approval of 22 statements.</div></div><div><h3>Conclusions</h3><div>There is a lack of uniformity in diagnosing overweight and obesity in Latin America, especially in the choice of growth charts and cutoff points for the pediatric population.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 428-450"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to the comments on the article “Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG”","authors":"L.R. Valdovinos-García","doi":"10.1016/j.rgmxen.2025.09.021","DOIUrl":"10.1016/j.rgmxen.2025.09.021","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 3","pages":"Pages 505-506"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociación Mexicana de Gastroenterología) - AMNM (Asociación Mexicana de Neurogastroenterología y Motilidad) expert joint review","authors":"O. Gómez-Escudero ,&nbsp;J.M. Remes-Troche ,&nbsp;E. Coss-Adame ,&nbsp;K.R. García-Zermeño ,&nbsp;J. Aquino-Matus ,&nbsp;J. Jiménez-Pavón ,&nbsp;L.R. Valdovinos-García ,&nbsp;M.A. Vargas-Martínez ,&nbsp;M. Amieva-Balmori ,&nbsp;J.S. Arenas-Martínez ,&nbsp;F.A. Félix-Téllez ,&nbsp;P.C. Gómez-Castaños ,&nbsp;M. Mejía-Rivas ,&nbsp;M.A. Valdovinos-Díaz ,&nbsp;G. Vázquez-Elizondo ,&nbsp;A.S. Villar-Chávez ,&nbsp;C.P. Gyawali","doi":"10.1016/j.rgmxen.2024.12.001","DOIUrl":"10.1016/j.rgmxen.2024.12.001","url":null,"abstract":"<div><div>Disorders of gut-brain interaction (DGBI) are characterized by alterations in both central and peripheral gut-brain axis (GBA)-related stimuli, and include esophageal, gastroduodenal, intestinal and anorectal disorders. Despite the fact that several pathophysiologic mechanisms are involved, the mainstay of treatment is neuromodulators, a heterogeneous group of drugs that act on pathways related to central and peripheral pain processing. This expert review by both the AMG (Asociación Mexicana de Gastroenterología) and AMNM (Asociación Mexicana de Neurogastroenterología y Motilidad) summarizes a series of updated clinical recommendations based on an exhaustive review of the literature, regarding the use of neuromodulators for DGBI, and is grouped into six sections: pharmacologic principles, definition, classification, mechanism of action, indications and use in each DGBI subtype, up/downscaling strategies, combination therapy, adverse events, joint use along with psychiatry in the case of comorbidities, and non-pharmacologic neuromodulation. Furthermore, drug selection process tips and dose personalization according to individual groups and sensitivities are provided, and special cases with DGBI-psychiatric comorbidity, as well as overlap with another DGBI, are considered.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 252-287"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of quarterly meeting and email report of ADR, cecal intubation rate, and withdrawal time on personal and group quality measures in colonoscopy","authors":"F.I. Téllez-Ávila ,&nbsp;B. Bailey ,&nbsp;S. Dehmel ,&nbsp;M. Deneke ,&nbsp;K. Rude ,&nbsp;S. Inamdar ,&nbsp;M. García","doi":"10.1016/j.rgmxen.2024.11.004","DOIUrl":"10.1016/j.rgmxen.2024.11.004","url":null,"abstract":"<div><h3>Introduction</h3><div>Colonoscopy is the most utilized screening test for colorectal cancer (CRC). The adenoma detection rate (ADR), cecal intubation rate (CIR), and withdrawal time (WT) are established quality indicators (QIs) for colonoscopy. The aim was to measure the effect of individual and group QIs in colonoscopy by providing quarterly meetings and email feedback on ADR, CIR, and WT.</div></div><div><h3>Material and methods</h3><div>This is a prospective study in 2 steps. In the initial phase, we aimed to collect the QIs in colonoscopy from our division and in the second step, we aimed to assess the impact of a quarterly report. <em>Pre-Intervention:</em> Using electronic medical records (EMRs), an automated method for calculating the ADR was devised. ADRs from 6 months were obtained. <em>Periodic Feedback:</em> Endoscopists received quarterly feedback during staff meetings and emails for 9 months. <em>Post-Intervention:</em> QIs were recalculated for 8 months, and physicians did not receive reports.</div></div><div><h3>Results</h3><div>Over 23 months, 1,137 screening colonoscopies were conducted. Seven gastroenterologists participated, distributed into high (n = 6) and low (n = 1) detector groups. The mean patient age was 58.6 ± 9.2 years, with 659 (57.9%) females. Moderate sedation was used in 892 (78.4%) cases. QIs did not show significant improvement during the feedback or post-intervention periods compared with the pre-intervention period. Endoscopists initially categorized as «low detectors» exhibited the most substantial improvement, with the ADR increasing from 23.5% to 61.5% (<em>P</em> &lt; .001).</div></div><div><h3>Conclusion</h3><div>Quarterly feedback and email reports did not significantly improve colonoscopy quality measures. Regarding the ADR, the intervention’s impact was most prominent in «low detectors».</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 207-213"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"C-reactive protein as a predictor of complicated acute cholecystitis: A cohort study","authors":"G. Renau ,&nbsp;D. Abelló ,&nbsp;F. Sabench ,&nbsp;J. Doménech ,&nbsp;A. Sánchez","doi":"10.1016/j.rgmxen.2025.02.004","DOIUrl":"10.1016/j.rgmxen.2025.02.004","url":null,"abstract":"<div><h3>Introduction</h3><div>The Tokyo Guidelines for the severity classification of acute cholecystitis (AC) include leukocytosis as a severity classifier, without considering C-reactive protein (CRP). Our aim was to determine which of the two variables has a greater predictive capacity for local complications in AC (LCAC).</div></div><div><h3>Material and methods</h3><div>A retrospective single-center study was conducted on patients that underwent emergency cholecystectomy within the time frame of June 2022 and December 2023. The variables associated with LCAC were analyzed and an ROC analysis was carried out.</div></div><div><h3>Results</h3><div>The multivariate analysis of 145 patients identified the following associations with LCAC: CRP (<em>p</em> &lt; 0.001; OR 11.8), AUC of 0.88 (<em>p =</em> 0.029), and cutoff point of 4 mg/dl (88% sensitivity, 71% specificity); leukocytosis (<em>p</em> &lt; 0.031; OR 5), AUC of 0.81(<em>p</em> = 0.037), and cutoff point of 11.09 x 10⁹/l (78% sensitivity, 70% specificity).</div></div><div><h3>Conclusions</h3><div>CRP may have a higher predictive capacity for LCAC than leukocytosis.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 2","pages":"Pages 330-333"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144268112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}